Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    "hereditary hemorrhagic telangiectasia"
Show Display Options
RSS Create an RSS feed from your search for:
"hereditary hemorrhagic telangiectasia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention:
2 Completed Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia
Interventions: Drug: Tranexamic acid first, than placebo;   Drug: First placebo, than Tranexamic acid.
3 Unknown  Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
4 Unknown  Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
5 Active, not recruiting Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
6 Completed Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Conditions: Epistaxis;   Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: Sodium tetradecyl sulfate (sotradecol)
7 Withdrawn Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia (HHT);   Nosebleeds
Intervention: Drug: Ranibizumab
8 Unknown  Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Conditions: Hereditary Hemorrhagic Telangiectasia;   Idiopathic Vascular Ectasia
Intervention: Drug: Pomalidomide
9 Completed Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention:
10 Terminated Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions: Drug: Bevacizumab;   Drug: placebo
11 Completed Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: soy protein isolate
12 Completed Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: Tamoxifen
13 Recruiting Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia (HHT)
Intervention: Other: questionnaire
14 Recruiting Graded TTCE for Post-Embolization PAVM Monitoring
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Other: Transthoracic Contrast Echocardiogram
15 Recruiting MRA With Feraheme in HHT
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention:
16 Completed Screening Behavior in Adults With Hereditary Hemorrhagic Telangiectasia
Conditions: Osler-Rendu-Weber Disease;   Osler-Rendu Disease;   Telangiectasia, Hereditary Hemorrhagic
Intervention:
17 Completed Frequency of Common Medical Conditions in People With and Without HHT
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Other: Questionnaire
18 Not yet recruiting Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions: Drug: Mupirocin;   Other: Placebo
19 Recruiting Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia
Intervention: Drug: Ferrous sulphate 200mg oral tablet
20 Completed Hereditary Haemorrhagic Telangiectasia Flight Safety Study
Condition: Hereditary Haemorrhagic Telangiectasia
Interventions: Other: Aeroplane flight in the past- no active intervention for study;   Other: Questionnaire

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.